An offering was filed with and declared effective by the SEC on August 21, 2025, with Morgan Stanley and TD Cowen serving as joint book-running managers for Sana Biotechnology.

The entities involved

• Sana Biotechnology →

  biotechnology company

  Nothing else this week.

• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• SB Energy plans a U.S. IPO seeking a Nasdaq Global Select Market listing, with Morgan Stanley, Goldman Sachs, and Citigroup as joint lead book-running managers.Sep 2
• TD Cowen and Morgan Stanley were appointed as lead book-running managers for a new offering in New York.Fri 03:31
• Goldman Sachs and Morgan Stanley engaged in joint book-running management of a bond issuance for AstraZeneca.Aug 25
• Electra Therapeutics is seeking an IPO listing on Nasdaq, retaining TD Cowen as joint bookrunner and filing S-1.Aug 28
• BMB is filing an IPO with the SEC and proposing a listing on the NYSE, with Morgan Stanley and Broadridge Financial Solutions acting as joint bookrunners.Aug 28